Perfluoro-octanoic acid impairs sperm motility through the alteration of plasma membrane.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
May 2020
Historique:
received: 05 08 2019
accepted: 19 11 2019
pubmed: 30 11 2019
medline: 5 2 2021
entrez: 29 11 2019
Statut: ppublish

Résumé

Perfluoroalkyl-substances (PFAS) are chemical additives considered harmful for humans. We recently showed that accumulation of perfluoro-octanoic acid (PFOA) in human semen of exposed subjects was associated with altered motility parameters of sperm cells, suggesting direct toxicity. To determine whether direct exposure of human spermatozoa to PFOA was associated to impairment of cell function. Spermatozoa isolated from semen samples of ten normozoospermic healthy donors were exposed up to 2 h to PFOA, at concentrations from 0.1 to 10 ng/mL. Viability and motility parameters were evaluated by Sperm Class Analyser. Cell respiratory function was assessed by both mitochondrial probe JC-1 and respiratory control ratio (RCR) determination. Sperm accumulation of PFOA was quantified by liquid chromatography-mass spectrometry. Expression of organic ion-transporters OATP1 and SLCO1B2 was assessed by immunofluorescence and respective role in PFOA accumulation was evaluated by either blockade with probenecid or membrane scavenging through β-cyclodextrin (β-CD). Plasma membrane fluidity and electrochemical potential (ΔΨp) were evaluated, respectively, with Merocyanine-540 and Di-3-ANEPPDHQ fluorescent probes. Compared to untreated controls, a threefold increase of the percentage of non-motile sperms was observed after 2 h of exposure to PFOA regardless of the concentration of PFOA, whilst RCR was significantly reduced. Only scavenging with β-CD was effective in reducing PFOA accumulation, suggesting membrane involvement. Altered membrane fluidity, reduced ΔΨp and sperm motility loss associated with exposure to PFOA were reverted by β-CD treatment. PFOA alters human sperm motility through plasma-membrane disruption, an effect recovered by incubation with β-CD.

Identifiants

pubmed: 31776969
doi: 10.1007/s40618-019-01152-0
pii: 10.1007/s40618-019-01152-0
doi:

Substances chimiques

Caprylates 0
Fluorocarbons 0
Organic Anion Transporters 0
SLCO1A2 protein, human 0
perfluorooctanoic acid 947VD76D3L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-652

Références

Molecules. 2016 Dec 20;21(12):
pubmed: 27999408
Environ Pollut. 2010 Aug;158(8):2546-52
pubmed: 20573431
Toxicol Appl Pharmacol. 2009 Feb 1;234(3):300-5
pubmed: 19026671
J Biochem Toxicol. 1992 Spring;7(1):31-6
pubmed: 1375295
Integr Environ Assess Manag. 2011 Oct;7(4):513-41
pubmed: 21793199
Adv Anat Embryol Cell Biol. 2016;220:93-106
pubmed: 27194351
Mol Hum Reprod. 2017 Aug 1;23(8):521-534
pubmed: 28521061
Food Chem Toxicol. 2016 Nov;97:243-255
pubmed: 27637925
Biochim Biophys Acta. 2000 Nov 10;1469(3):197-235
pubmed: 11063883
J Physiol. 2010 Dec 1;588(Pt 23):4667-72
pubmed: 20679352
Environ Health Perspect. 2009 Jun;117(6):923-7
pubmed: 19590684
Sci Rep. 2016 Jul 20;6:29667
pubmed: 27436542
Hum Reprod. 1997 Dec;12(12):2720-3
pubmed: 9455842
Biochim Biophys Acta. 1985 May 28;815(3):486-98
pubmed: 3995037
Mol Hum Reprod. 2005 Sep;11(9):683-91
pubmed: 16192296
Cell Tissue Res. 1998 Aug;293(2):177-87
pubmed: 9662641
J Androl. 2004 Sep-Oct;25(5):797-810
pubmed: 15292113
Environ Int. 2019 Mar;124:482-492
pubmed: 30684806
PLoS One. 2012;7(8):e42474
pubmed: 22879996
Cell Biochem Biophys. 2003;38(2):161-90
pubmed: 12777713
Reprod Biol Endocrinol. 2019 Jan 6;17(1):4
pubmed: 30611299
J Colloid Interface Sci. 2018 Feb 1;511:474-481
pubmed: 29073553
Crit Rev Toxicol. 2004 Jul-Aug;34(4):351-84
pubmed: 15328768
Int J Androl. 2008 Apr;31(2):161-9
pubmed: 18315716
Scand J Clin Lab Invest. 1996 Aug;56(5):401-7
pubmed: 8869662
Mol Reprod Dev. 2006 Dec;73(12):1591-9
pubmed: 16897700
Reprod Toxicol. 2018 Dec;82:103-110
pubmed: 30393182
Acta Eur Fertil. 1990 Nov-Dec;21(6):305-8
pubmed: 2132483
Environ Sci Technol. 2018 Sep 18;52(18):10433-10440
pubmed: 30148610
J Pharmacol Exp Ther. 2002 Mar;300(3):918-24
pubmed: 11861798
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1259-1271
pubmed: 30403786
Environ Health Perspect. 2007 Nov;115(11):1596-602
pubmed: 18007991
Mech Dev. 2018 Dec;154:33-43
pubmed: 29694849
Ecotoxicol Environ Saf. 2019 Jun 15;174:66-74
pubmed: 30822669
J Biol Chem. 1997 Nov 14;272(46):28875-81
pubmed: 9360955
Int J Hyg Environ Health. 2009 May;212(3):239-70
pubmed: 18565792
Andrologia. 2015 Nov;47(9):1012-9
pubmed: 25382683
Chemosphere. 2012 Sep;88(11):1269-75
pubmed: 22494529
Environ Health Perspect. 2007 Nov;115(11):1677-82
pubmed: 18008003
Biochim Biophys Acta. 1993 Jun 18;1149(1):175-9
pubmed: 8318528
Chemosphere. 2018 Jun;200:116-123
pubmed: 29476956
Cell. 2010 Feb 5;140(3):327-37
pubmed: 20144758
Biochim Biophys Acta. 1983 Jul 27;732(2):387-93
pubmed: 6871207
Mol Reprod Dev. 2005 Nov;72(3):386-95
pubmed: 16044473
Biochim Biophys Acta. 1994 Mar 3;1211(2):125-49
pubmed: 8117740
J Toxicol Sci. 2003 May;28(2):49-57
pubmed: 12820537
Int J Androl. 2008 Jun;31(3):337-45
pubmed: 17573845
Biol Reprod. 2001 Aug;65(2):462-70
pubmed: 11466214
Environ Sci Technol. 2011 Sep 1;45(17):7465-72
pubmed: 21805959
J Physiol Pharmacol. 2018 Jun;69(3):
pubmed: 30149367
Pharmacol Toxicol. 1989 Oct;65(4):274-7
pubmed: 2587510
Chemosphere. 2012 Jan;86(3):308-14
pubmed: 22104337
Environ Sci Technol. 2001 Apr 1;35(7):1339-42
pubmed: 11348064
Environ Health Perspect. 2004 Aug;112(11):1204-7
pubmed: 15289168
Chem Res Toxicol. 2012 Jan 13;25(1):35-46
pubmed: 21985250
Environ Health Perspect. 2003 Sep;111(12):1485-9
pubmed: 12948888
Int J Androl. 2011 Dec;34(6 Pt 2):e554-65
pubmed: 21623830
Mutat Res. 2019 May;841:8-13
pubmed: 31138412
Chem Res Toxicol. 2018 Apr 16;31(4):277-284
pubmed: 29589912
Toxicol Sci. 2007 Oct;99(2):366-94
pubmed: 17519394
Environ Int. 2012 Apr;40:187-195
pubmed: 21864910

Auteurs

I Šabović (I)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.

I Cosci (I)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Familial Cancer Clinic, Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy.

L De Toni (L)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.

A Ferramosca (A)

Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy.

M Stornaiuolo (M)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.

A Di Nisio (A)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.

S Dall'Acqua (S)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy.

A Garolla (A)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.

C Foresta (C)

Department of Medicine and Unit of Andrology and Reproductive Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy. carlo.foresta@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH